Vuelta a España organiser releases statement on Chris Froome's salbutamol test result

After the news broke that Chris Froome returned an adverse analytical finding for salbutamol during the 2017 Vuelta a España, the race's organiser issued a brief statement

Peloton on stage seven of the 2017 Vuelta a España.

(Image credit: Yuzuru Sunada)

The organiser of the Vuelta a España has issued a brief statement in the wake of the news on Wednesday that Chris Froome returned an abnormal test result for salbutamol during the 2017 race.

Both the UCI and Froome's team, Sky, issued statements on Wednesday morning confirming that Froome had a returned an adverse analytical finding (AAF) for asthma medication salbutamol from a urine sample taken after stage 18 of the race. Froome went on to win the race overall.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1